Skip to main content
. 2016 Nov 24;26:16079. doi: 10.1038/npjpcrm.2016.79

Table 3. Summary of number of patients with at least one critical error or overall error using ELLIPTA vs comparator inhaler.

(A) COPD patients
  ELLIPTA vs
  DISKUS (N=171) MDI (N=80) Turbuhaler (N=100) Handihaler (N=118) Breezhaler (N=98)
Critical errors, n (%) 9 (5) vs 75 (44) 10 (13) vs 48 (60) 8 (8) vs 44 (44) 17 (14) vs 57 (48) 13 (13) vs 45 (46)
P value <0.001 <0.001 <0.001 <0.001 <0.001
Overall errors, n (%) 52 (30) vs 112 (65) 25 (31) vs 68 (85) 31 (31) vs 71 (71) 51 (43) vs 73 (62) 30 (31) vs 55 (56)
P value <0.001 <0.001 <0.001 <0.001 <0.001
(B) Asthma patients
  ELLIPTA vs
  DISKUS (N=70) MDI (N=32) Turbuhaler (N=60)
Critical errors, n (%) 3 (4) vs 9 (13) 2 (6) vs 8 (25) 3 (5) vs 20 (33)
Pvalue 0.221 0.074 <0.001
Overall errors, n (%) 15 (21) vs 22 (31) 9 (28) vs 13 (41) 15 (25) vs 28 (47)
P value 0.186 0.217 0.022

Abbreviation: COPD, chronic obstructive pulmonary disease.